<br>        Inclusion Criteria:<br><br>          -  Patient greater than or equal to 18 years old.<br><br>          -  Patient is classified as high risk for acute allograft rejection of DGF. Must have<br>             had at least 1 donor or 1 recipient variable for high risk.<br><br>          -  Patient will be a recipient of a solitary cadaveric renal allograft.<br><br>          -  Women of childbearing potential must have had a negative pregnancy test (serum or<br>             urine).<br><br>          -  Man or woman agrees to practice medically acceptable contraception (i.e. barrier or<br>             pharmacologic) for a minimum of 3 months following study drug administration.  In<br>             addition, women were recommended to practice contraception for 1 year following<br>             transplantation, or per local standard.<br><br>          -  Patient agrees to participate in the study and sign an informed consent.<br><br>          -  Patient has no known contraindication to the administration of rabbit anti-thymocyte<br>             globulin or basiliximab.  Patient has no history of hypersensitivity to basiliximab.<br><br>          -  Patient is dialysis-dependent at the time immediately prior to transplantation.<br><br>        Exclusion Criteria:<br><br>          -  Patient has received an investigational medication within the past 30 days.<br><br>          -  Patient has a history of malignancy within 2 years, with the exception of adequately<br>             treated localized squamous basal cell carcinoma of the skin without evidence of<br>             recurrence.<br><br>          -  Patient is currently abusing drugs or alcohol.<br><br>          -  Patient is known or suspected to have an active infection or be seropositive for<br>             hepatitis B surface antigen (HBsAg), hepatitis C (HCV), or human immunodeficiency<br>             virus (HIV).<br><br>          -  Patient is a multiple organ transplant recipient.<br><br>          -  Patient is on any type of immunosuppression (i.e. prior transplant recipient still on<br>             immunosuppression, or patient is receiving systemic steroids for any medical<br>             condition).<br><br>          -  Patient, who, in the opinion of the investigator, has significant medical or<br>             psychosocial problems or unstable disease states which would preclude enrollment.<br>             Examples of significant medical problems include, but are not limited to, morbid<br>             obesity or severe cardiac disease.<br><br>          -  Kidneys that are to be implanted en bloc or from donors less than 6 years old.<br><br>          -  Kidneys from donors that are known or suspected to have an active infection with or<br>             be seropositive for HBsAg, hepatitis B core antibody (HBcAb), HCV, or HIV.<br><br>          -  Kidneys from donors that have received investigational therapies designed to reduce<br>             the impact of ischemia reperfusion, DGF, or other donor-related immune events.<br><br>          -  Donor kidney is preserved by cold storage (with or without machine preservation) for<br>             less than 16 hours, with the exception of kidneys from non-heart-beating donors or<br>             kidneys from donors greater than 50 years old or donors with a SCr above 2.5mg/dL.<br>